Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06631144 · ClinicalTrials.gov registry record · NA

A Spanish-language Caregiver-Enabled Care Program

A NA study of Alzheimer Disease and Dementia, sponsored by Ceresti Health.

Active
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT06631144 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by Ceresti Health. The registered enrollment target is 270 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06631144, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by Ceresti Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to develop and test the feasibility of a nonmedical digital health intervention, the Spanish-language Caregiver-Enabled Care Program (CECP), with Spanish-speaking caregivers of persons with dementia (PWD). CECP is a nonmedical digital population health intervention that provides personalized education, proactive 1:1 human coaching, and remote monitoring, all delivered via a dedicated tablet shipped to the caregiver's home at no cost to the caregiver or PWD. For this study, the investigators are recruiting 135 patient/caregiver dyads.

Conditions Studied

Alzheimer Disease Dementia Caregiver Burden Caregiver Dementia Alzheimers

Interventions

  • BEHAVIORAL Spanish-language Caregiver-Enabled Care Program (CECP)

Study Locations (1)

California

  • Ceresti Health - Carlsbad

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2024-12-04
Est. Completion 2026-02-27
Phase NA

Sponsor

Ceresti Health

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06631144

The ClinicalTrials.gov registry entry for NCT06631144 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (90% lower). The listed sponsor is Ceresti Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Spanish-language Caregiver-Enabled Care Program (CECP) is the first listed.

NCT06631144 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06631144 about?

NCT06631144 is a clinical study titled "A Spanish-language Caregiver-Enabled Care Program". The purpose of the study is to develop and test the feasibility of a nonmedical digital health intervention, the Spanish-language Caregiver-Enabled Care Program (CECP), with Spanish-speaking caregivers of persons with dementia (PWD). CECP is a nonmedical digital population health intervention that p...

What is the current status of trial NCT06631144?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-12-04. Estimated completion is 2026-02-27.

What conditions does trial NCT06631144 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Caregiver Burden, Caregiver, Dementia Alzheimers.

What interventions are being tested in trial NCT06631144?

The interventions under investigation include: Spanish-language Caregiver-Enabled Care Program (CECP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06631144?

This trial is sponsored by Ceresti Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06631144 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Dementia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.